The Blue Ridge Institute for Medical Research ranks Duke Anesthesiology the #3 anesthesiology clinical science department in the country for National Institutes of Health funding, securing our reputation as one of the premier research institutions in anesthesiology.
Congratulations to Duke Anesthesiology’s Mara Serbanescu, MD, on being among the six Duke University School of Medicine faculty members selected to receive a Physician-Scientist Strong Start Award, designed to support outstanding lab-based clinician-scientists.
A new study led by Duke Health researchers, including Duke Anesthesiology's Dr. Paul Wischmeyer (co-lead author), and published in Clinical Nutrition suggests that probiotics could be a relatively simple and inexpensive approach to treating people after a COVID exposure.
New research led by Duke Anesthesiology’s Dr. Leah Acker and published in the British Journal of Anaesthesia reveals that a simple preoperative electroencephalogram measurement detects a signal of cognitive vulnerability when patients are asked to close, then open their eyes.
It was another successful American Society of Anesthesiologists (ASA) meeting for Duke Anesthesiology! View the photo gallery and read the full recap from San Francisco!
Newly-published research in JAMA, led by Duke Anesthesiology’s Drs. Sairam Jabba and Sven-Eric Jordt, reveals the additives in “non-menthol” cigarettes are designed to mimic the effects of menthol, facilitating smoking initiation.
New research led by Duke Anesthesiology’s Dr. Michael Devinney and published in the Annals of Neurology reveals that patients who develop postoperative delirium have greater increases in permeability in the blood-brain barrier, pointing the way toward potential new therapies to prevent this common postoperative complication.
Congratulations to Ru-Rong Ji, PhD, on receiving a three year $2,569,851 grant from the National Institutes of Health for research aimed at providing novel insights into distinct actions of checkpoint pathway activators and inhibitors for the management of different types of pain.
Congratulations to Andrea Nackley, PhD, on receiving a two-year $1,846,202 R61 grant to develop novel Adrb3 antagonists for the treatment of chronic primary pain conditions as part of the NIH’s Helping to End Addiction Long-term (HEAL) Initiative.
Congratulations to Melissa Bauer, DO, on being awarded a three-year $3,482,862 UH3 grant from the National Institutes of Health for phase II of a five-year study that aims to reduce maternal morbidity and mortality from maternal infection.